Exact Sciences
EXAS
#1383
Rank
S$17.04 B
Marketcap
$92.26
Share price
2.34%
Change (1 day)
-10.31%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$4.53 B

According to Exact Sciences's latest financial reports the company's total liabilities are S$4.53 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$4.39 B2.92%
2022-12-31S$4.26 B-4.02%
2021-12-31S$4.44 B25.06%
2020-12-31S$3.55 B117.15%
2019-12-31S$1.63 B42.58%
2018-12-31S$1.14 B998.87%
2017-12-31S$0.10 B72.99%
2016-12-31S$60.41 M14.8%
2015-12-31S$52.63 M67.09%
2014-12-31S$31.49 M119.76%
2013-12-31S$14.33 M-13.39%
2012-12-31S$16.54 M-5.05%
2011-12-31S$17.42 M-19.31%
2010-12-31S$21.59 M-21.88%
2009-12-31S$27.65 M130.81%
2008-12-31S$11.97 M-0.26%
2007-12-31S$12.01 M-12.09%
2006-12-31S$13.66 M-37.95%
2005-12-31S$22.01 M-17.63%
2004-12-31S$26.73 M-30.05%
2003-12-31S$38.21 M87.64%
2002-12-31S$20.36 M166.18%
2001-12-31S$7.65 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$0.44 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.13 B-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
S$28.41 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
S$79.25 B 1,647.92%๐Ÿ‡ซ๐Ÿ‡ท France